Trim the Leaves, Buy the Blood

I can’t possibly underscore how horrible this summer has been for me as a cannabis investor... Three cannabis stocks on sale... You are receiving this email because you subscribed to Outsider Club. [Click here]( to manage your e-mail preferences. [Outsider Club logo] Trim the Leaves, Buy the Blood [Jimmy Mengel Photo] By [Jimmy Mengel]( Written Oct. 11, 2019 I can’t possibly underscore how horrible this summer has been for me as a cannabis investor. It doesn’t get much worse than this... I feel like Indiana Jones in the Temple of Doom, when the walls start closing in… It’s one thing to try and catch a falling knife — it’s a far different scenario when you are trying to catch an entire room of falling daggers. In all of my years of covering cannabis, I haven't seen an entire sector pull back like this one. The industry is going through a major shift and only the strongest of the cannabis companies will survive. While it's never easy to watch your stocks take a hit, I treat myself to these opportunities like a kid in a candy store. I dollar-cost average my favorite long-term stocks, and I buy the ones that used to be too rich for my blood. The industry has all been painted with the same bloody brush, which simply isn't the reality for many of the companies that are playing the long game, and have the cash and assets to weather it. In fact, I have [three cannabis stocks I'm buying]( that are no brainers after the summer bloodbath. Mengel: Off The Record Mengel is the most [politically incorrect]( investor in America, hands down... He’s also [UNDEFEATED]( — of the 88 investment recommendations he’s issued over the last six years, NONE have been losers. His average gain is an incredible 140%. And today, [for the first time ever](, Jimmy is giving you the chance to be a part of his [inner circle.]( You may disagree with [his approach](, but you can’t deny his millionaire-making power. [If anything, you will be highly entertained.]( You can see the crash in the Horizons Marijuana Life Sciences Index ETF (HMMJ.TO) — which holds many of the same cannabis stocks that I do in my advisory services. Here are the top holdings: - CANOPY GROWTH CORP — 10.39% - AURORA CANNABIS INC — 10.02% - CRONOS GROUP INC — 9.71% - TILRAY INC — 7.89% - GW PHARMACEUTICALS PLC — 7.57% That fund is down over 30% since the middle of August: [horizons life sciences] This is "Fear Selling 101". I like the old trope of buying "when there is blood in the streets", and it has typically been when I've done my best investing. But enough of the doom, gloom, and bodily fluids... The industry has already seen some massive breakthroughs this month. Canada is set to legalize edibles later this month. On October 17th, it will be legal to sell cannabis extracts in Canada. This is what we’ve been waiting for. “The edibles market is estimated to be worth at least $1.6 billion a year in Canada, with cannabis-infused beverages adding a further $529 million,” according to Jennifer Lee from Deloitte. “The introduction of cannabis-infused edibles will threaten the alcohol industry.” That will be a boon to companies with beverage divisions. We have also made some serious progress here in the United States... [3 Cannabis Stocks Positioned for 8,000% Gains]( America’s cannabis market just overcame its last great obstacle. Now the market is about to receive an $800 billion boost. Launching three tiny companies to meteoric heights. [Click here to see the full story.]( Last week, the [Secure and Fair Enforcement (SAFE) Act]( cleared a House vote 321 – 103. That — in and of itself — is a huge step forward in allowing the industry to operate exactly as it should: as a legitimate business. The legislation would protect banks that service state-legal marijuana businesses from being penalized by federal regulators. What’s more, the bill passed with broad bipartisan support. Almost half of Republicans voted with the Democrats to get it passed. It also has the support of over 50 state banking associations, the National Association of State Treasurers, the top financial regulators of 25 states, a majority of state attorneys general, and governors of 20 states, among others. Once the U.S. federal situation becomes more clear, many of our U.S. positions will be in much firmer shape. Every step helps... and if the SAFE Act passes in the Senate, that will be more like a leap. Considering that 33 Republicans already signed on as co-sponsors, I'm counting on it... 5G Goes Live in Norway 5G technology is brilliant... connecting devices with unmatched speed, intricacy, and more reliability than we’ve ever seen before. Towers and networks are being built around the globe. And dear reader, 5G has reached Norway. Telecommunication titan Telenor launched a 5G test run in Scandinavia. Make no mistake: 5G will get much bigger. Sigve Brekke, Telenor Group President and CEO, had this to say: Exploring this technology here in Norway means that we can learn, test and continuously improve as we gradually introduce 5G to our markets. That’s just Norway. The U.S. will be completely 5G compliant by 2020. That’s right — in only a few months. Industries ranging from health care to manufacturing and many more can’t wait to upgrade their systems with 5G. That’s how game changing 5G is. Luckily for us, there’s still time to get rich from this revolutionary technology. Investment expert Jason Stutman has found three stocks that will skyrocket with the growing 5G market. [Click here now to learn more.]( Investors who have the constitution for the volatility of the short term and happen to pick the winners will be rewarded incredibly. I spoke with one CEO about the recent turn, and he was quite frank. "We’ll be looking back on this space, five years from now, and people will be laughing: How did I not buy when it was under a $2 billion valuation? It takes a strong stomach, but we have anti-nausea cannabis for that.” I happen to have the stomach for it, which is why I just put together a report about my three favorite cannabis stocks that are trading at an amazing discount. I'm doubling down in a big way. Now, I'm convinced that with any investment, you really need to be diversified. That's why I've taken trips all over the world to visit cannabis companies operating in different countries with different areas of expertise. In an area like cannabis, you need to spread those investments far and wide. After countless hours in planes, greenhouses, and corporate offices, I've settled on my favorite three... #1: The first involves a company with a massive 69-acre greenhouse in Colombia that’s on the verge of selling an estimated $175 million worth of medical marijuana each year. #2: The second will allow you to profit from Canada’s legalization of cannabis-infused beverages which, according to the Minister of Health, will take place on October 17, 2019. #3: The third deals with a company headquartered in Australia that is not only tapping into the growing hemp market but is also building a 60-acre greenhouse that will produce up to two tons of medical cannabis by as early as next year. If you've never bought a cannabis stock before, now is the time. I couldn't dream up a better entry point for these stocks — in fact, I'm jealous that you'd be getting in this cheap. But you be the judge. Watch [the three interrogations]( I conducted with the companies I mentioned above, [right here](. Godspeed, [Jimmy Mengel] Jimmy Mengel [follow basic]( [@mengeled on Twitter]( Jimmy is a managing editor for [Outsider Club]( and the investment director of the personal finance advisory, [The Crow's Nest,](and cannabis stocks advisory, [The Marijuana Manifesto.]( For more on Jimmy, check out his editor's [page](. *Follow Outsider Club on [Facebook]( and [Twitter](. Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [Marijuana Is Coming to Mexico]( [Gold Knows the Truth]( [James Dines on Gold: The Truth Isn't The Same Everywhere]( [The Bulls Will Have the Last Laugh]( [Don’t Forget We’re at War – And We’re Losing]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Outsider Club, please add newsletter@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Outsider Club](, Copyright © 2019, [Angel Publishing LLC]( & Outsider Club LLC, 111 Market Place #720, Baltimore, MD 21202. For Customer Service, please call (877) 303-4529. All rights reserved. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. Angel Publishing and Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. This letter is not intended to meet your specific individual investment needs and it is not tailored to your personal financial situation. Nothing contained herein constitutes, is intended, or deemed to be – either implied or otherwise – investment advice. Neither the publisher nor the editors are registered investment advisors. This letter reflects the personal views and opinions of Nick Hodge and that is all it purports to be. While the information herein is believed to be accurate and reliable it is not guaranteed or implied to be so. Neither Nick Hodge, nor anyone else, accepts any responsibility, or assumes any liability, whatsoever, for any direct, indirect or consequential loss arising from the use of the information in this letter. The information contained herein is subject to change without notice, may become outdated and may not be updated. Nick Hodge, entities that he controls, family, friends, employees, associates, and others may have positions in securities mentioned, or discussed, in this letter. No part of this letter/article may be reproduced, copied, emailed, faxed, or distributed (in any form) without the express written permission of Nick Hodge or the Outsider Club. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law.